Authors
Latest:
The Future of IgA Nephropathy TreatmentJonathan Barratt, PhD, FRCP, and Brad Rovin, MD, discuss the future of IgAN treatment, highlighting the BlyS/APRIL axis.
Latest:
Clinical Pearls for the Management of IPFSteven D. Nathan, MD, FCCP, and Fernando J. Martinez, MD, MS, share clinical pearls and advice for the management of IPF.
Latest:
Tips for Managing Generalized Pustular Psoriasis (GPP)Dermatologists Drs Tina Bhutani and Scott Boswell and patient Kanya Oul share resources and tools available to cope with generalized pustular psoriasis (GPP).
Latest:
Concluding Thoughts on Elamipretide in Dry AMD Patients with GAArshad Khanani, MD shares his excitement about the potential of elamipretide joining the treatment armamentarium in GA and his final thoughts on the topic.
Latest:
Emerging Treatments for Dry Eye DiseaseOphthalmologist experts provide an overview of emerging treatments for dry eye disease.
Latest:
The APAC Recap: ASPC 2024 Congress on CVD Prevention, with Viet Le, DMSc, PA-CIn this edition of the APAC Recap, Erin Pardee, PA-C, discusses the American Society of Preventive Cardiology 2024 Congress on CVD Prevention with Viet Le, DMSc, PA-C.
Latest:
Strategies to Improve Screening and Diagnosis of T1DDrs Robert Busch, Robin S. Goland, Kimberly Simmons, and Teresa Quattrin discuss strategies to facilitate screening of type 1 diabetes and improve management of disease.
Latest:
Future Directions for Atopic Dermatitis ManagementRaj J. Chovatiya, MD, PhD; Alexandra K. Golant, MD; Eric Simpson, MD, MCR; and Linda Stein Gold, MD, share clinical pearls and discuss the future treatment landscape for atopic dermatitis.
Latest:
Clinical trial data on IgAN for therapiesGerald B. Appel, MD, discusses the changing treatment landscape of IgAN.
Latest:
Introducing The Medical Sisterhood, with Mona Shahriari, MDThe Medical Sisterhood, hosted by Mona Shahriari, MD, is the latest multimedia program from HCPLive Dermatology!
Latest:
The Future of Plaque Psoriasis TherapyExpert dermatologists highlight the future of plaque psoriasis treatment, commenting on advances in therapy as well as increasing access to treatment.
Latest:
Recent Advances and Emerging Therapies in the Management of Alzheimer’s DiseaseIn this episode of MEDcast, expert geriatric psychiatrist and neurologist delve into the recent advances in the treatment of Alzheimer’s disease. We will discuss treatments that are on the cusp of FDA approval and others that are coming down the pipeline.
Latest:
Final Thoughts on Management of ADHDADHD experts share their final thoughts on the treatment and management of ADHD.
Latest:
Appropriate Guidance for CRC Screening Age, Role of Advocacy OrganizationsIn part 5 of our 5-part discussion, experts discuss their perspective on appropriate guidance for screening age and the future of CRC advocacy.
Latest:
Personalizing Dry Eye Disease Management: Medcast VideoExperts discuss the management of dry eye using conventional and new pharmacological treatments, as well as strategies for tailoring treatment approaches to individual patient characteristics.
Latest:
The Burden of Treatment Resistant DepressionRyan J. Wakim, MD, DFAPA, explores the causes and diagnostic criteria for treatment resistant depression. He also discusses the importance of comprehensive assessment and personalized approaches to care.
Latest:
Beyond Glucose Control - The Expanding Role of Incretins in Diabetes and Obesity ManagementIn this MEDcast episode, Diana Isaacs, PharmD, BC-ADM, CDCES, and Natalie Bellini, DNP, FNP-BC, interview Dr Juan Frias to explore the mechanism of GLP-1 and GIP agonists in diabetes and weight management and examine key findings from clinical trials for the latest GLP-1/GIP dual agonist.
Latest:
The Burden of Treatment Resistant DepressionRyan J. Wakim, MD, DFAPA, explores the causes and diagnostic criteria for treatment resistant depression. He also discusses the importance of comprehensive assessment and personalized approaches to care.
Latest:
Data on Early Itch Relief with JAK Inhibitors in Atopic DermatitisMedical experts review and comment on the effectiveness of oral JAK inhibitors in providing itch relief for patients with atopic dermatitis.
Latest:
Closing RemarksPanelists discuss how their approaches to treating patients with rheumatoid arthritis focus on personalized strategies that prioritize achieving remission while carefully monitoring safety and efficacy outcomes.
Latest:
Protecting Cardiorenal Function In Diabetic Kidney DiseaseDhiren Patel, PharmD, and Bob Busch, MD, interview Fatima Cody Stanford, MD, MPH, MPA, an obesity medicine specialist, to examine the cardiovascular (CV) impact of obesity and delve into the potential benefits of newer weight loss medications in mitigating CV risk and heart failure.
Latest:
Unmet Needs in the Treatment of PBCExperts in hepatology review the unmet needs in primary biliary cholangitis, commenting on liver transplant, ethnic disparities, management of pruritis, as well as other symptoms.
Latest:
How New Therapies Change Discussions Around Screening, Management of MASHIn the final installment in our 5-part video series, our pair of experts in hepatology touch upon how an approval for MASH would impact conversations around screening for asymptomatic patient populations.
Latest:
Exploring Procedural Treatments For Dry EyeExperts discuss treating dry eye with procedural therapies, focusing on common in-office and at-home treatments.
Latest:
Collaboration and Communication Across the Healthcare TeamThe expert panel concludes its discussion with insights on how collaboration and communication across various healthcare specialties improve the care of patients treated for iron deficiency anemia.
Latest:
Novel Systemic and Topical Treatment for Plaque PsoriasisIn this episode of MEDcast, expert dermatologists discuss exciting advancements in systemic therapies such as JAK inhibitors, and the latest breakthroughs in topical treatments for plaque psoriasis
Latest:
Clinical Pearls on AD ManagementAndrea Nguyen, PA, shares her clinical pearls on taking care of patients with AD.
Latest:
Resources Available for Patients with HIV Drug ResistanceThe panel concludes its discussion by talking about resources available for providers in managing their patients with HIV who experience drug resistance.
